203 related articles for article (PubMed ID: 12077582)
1. Increased interleukin 10, tumor necrosis factor alpha, and interleukin 6 levels in blister fluid of toxic epidermal necrolysis.
Correia O; Delgado L; Barbosa IL; Campilho F; Fleming-Torrinha J
J Am Acad Dermatol; 2002 Jul; 47(1):58-62. PubMed ID: 12077582
[TBL] [Abstract][Full Text] [Related]
2. Soluble interleukin 2 receptor and interleukin 1alpha in toxic epidermal necrolysis: a comparative analysis of serum and blister fluid samples.
Correia O; Delgado L; Roujeau JC; Le Cleach L; Fleming-Torrinha JA
Arch Dermatol; 2002 Jan; 138(1):29-32. PubMed ID: 11790164
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of the potential role of cytokines in toxic epidermal necrolysis.
Nassif A; Moslehi H; Le Gouvello S; Bagot M; Lyonnet L; Michel L; Boumsell L; Bensussan A; Roujeau JC
J Invest Dermatol; 2004 Nov; 123(5):850-5. PubMed ID: 15482470
[TBL] [Abstract][Full Text] [Related]
4. Blister fluid cytokines in cutaneous inflammatory bullous disorders.
Rhodes LE; Hashim IA; McLaughlin PJ; Friedmann PS
Acta Derm Venereol; 1999 Jul; 79(4):288-90. PubMed ID: 10429986
[TBL] [Abstract][Full Text] [Related]
5. Variable levels of apoptotic signal-associated cytokines in the disease course of patients with Stevens-Johnson syndrome and toxic epidermal necrolysis.
Yang Y; Li F; Du J; Shen Y; Lin J; Zhu X; Luo X; Liang J; Xu J
Australas J Dermatol; 2017 Aug; 58(3):e61-e67. PubMed ID: 27040133
[TBL] [Abstract][Full Text] [Related]
6. CD8+ lymphocytes in the blister fluid of severe acute cutaneous graft-versus-host disease: further similarities with toxic epidermal necrolysis.
Correia O; Delgado L; Barbosa IL; Domingues JC; Azevedo R; Vaz CP; Pimentel P
Dermatology; 2001; 203(3):212-6. PubMed ID: 11701973
[TBL] [Abstract][Full Text] [Related]
7. Interleukin-15 Is Associated with Severity and Mortality in Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis.
Su SC; Mockenhaupt M; Wolkenstein P; Dunant A; Le Gouvello S; Chen CB; Chosidow O; Valeyrie-Allanore L; Bellon T; Sekula P; Wang CW; Schumacher M; Kardaun SH; Hung SI; Roujeau JC; Chung WH
J Invest Dermatol; 2017 May; 137(5):1065-1073. PubMed ID: 28011147
[TBL] [Abstract][Full Text] [Related]
8. Soluble fractions of tumor necrosis factor-alpha, interleukin-6 and of their receptors in toxic epidermal necrolysis: a comparison with second-degree burns.
Paquet P; Piérard GE
Int J Mol Med; 1998 Feb; 1(2):459-62. PubMed ID: 9852250
[TBL] [Abstract][Full Text] [Related]
9. Serum and blister-fluid elevation and decreased epidermal content of high-mobility group box 1 protein in drug-induced Stevens-Johnson syndrome/toxic epidermal necrolysis.
Carr DF; Wang CW; Bellón T; Ressel L; Nwikue G; Shrivastava V; Bergfeld W; Jorgensen AL; Chung WH; Pirmohamed M
Br J Dermatol; 2019 Jul; 181(1):166-174. PubMed ID: 30613954
[TBL] [Abstract][Full Text] [Related]
10. Epidermal interleukin-8 and its receptor CXCR2 in drug-induced toxic epidermal necrolysis.
Paquet P; Ribbens C; Piérard GE
Clin Exp Dermatol; 2007 Nov; 32(6):728-32. PubMed ID: 17714530
[TBL] [Abstract][Full Text] [Related]
11. Measurement of cytokine expression and Langerhans cell migration in human skin following suction blister formation.
Dearman RJ; Bhushan M; Cumberbatch M; Kimber I; Griffiths CE
Exp Dermatol; 2004 Jul; 13(7):452-60. PubMed ID: 15217366
[TBL] [Abstract][Full Text] [Related]
12. Acute blistering diseases on the burn ward: Beyond Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis.
Richer V; Bouffard D; Bélisle A; Duranceau L; Perreault I; Provost N
Burns; 2013 Sep; 39(6):1290-6. PubMed ID: 23597847
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of tumor necrosis factor improves conventional steroid therapy for Stevens-Johnson syndrome/toxic epidermal necrolysis in a cohort of patients.
Ao S; Gao X; Zhan J; Ai L; Li M; Su H; Tang X; Chu C; Han J; Wang F
J Am Acad Dermatol; 2022 Jun; 86(6):1236-1245. PubMed ID: 35121075
[TBL] [Abstract][Full Text] [Related]
14. Increased serum and blister fluid levels of creatine kinase in patients with toxic epidermal necrolysis.
Caux F; Chosidow O; Philippon C; Roujeau JC; Revuz J
Br J Dermatol; 1994 Mar; 130(3):337-41. PubMed ID: 8148275
[TBL] [Abstract][Full Text] [Related]
15. Study on the T-helper cell 1/2 cytokine profile in blister fluid of patients with herpes zoster and its clinical significance.
Zhang M; Wu N; Yang L; Zhang J; Sun X; Zhong S; Ma X; Wang Y
J Dermatol; 2011 Dec; 38(12):1158-62. PubMed ID: 21954956
[TBL] [Abstract][Full Text] [Related]
16. Comparison of reporting of Stevens-Johnson syndrome and toxic epidermal necrolysis in association with selective COX-2 inhibitors.
La Grenade L; Lee L; Weaver J; Bonnel R; Karwoski C; Governale L; Brinker A
Drug Saf; 2005; 28(10):917-24. PubMed ID: 16180941
[TBL] [Abstract][Full Text] [Related]
17. Blister fluid composition in a pediatric patient with toxic epidermal necrolysis.
Gandhi M; Kowal-Vern A; An G; Hanumadass M
J Burn Care Res; 2008; 29(4):671-5. PubMed ID: 18535474
[TBL] [Abstract][Full Text] [Related]
18. Genetic association of IFN-γ +874T/A polymorphism in Mexican patients with drug-induced Stevens-Johnson syndrome/toxic epidermal necrolysis.
Charli-Joseph Y; Lima G; Ramos-Bello D; Aguilar D; Orozco-Topete R; Llorente L
Arch Dermatol Res; 2013 May; 305(4):353-7. PubMed ID: 23224615
[TBL] [Abstract][Full Text] [Related]
19. Anticonvulsant-induced toxic epidermal necrolysis: monitoring the immunologic response.
Leyva L; Torres MJ; Posadas S; Blanca M; Besso G; O'Valle F; del Moral RG; Santamaría LF; Juárez C
J Allergy Clin Immunol; 2000 Jan; 105(1 Pt 1):157-65. PubMed ID: 10629466
[TBL] [Abstract][Full Text] [Related]
20. Gender-specific differences in sex hormones and cytokines in patients undergoing major abdominal surgery.
Scheingraber S; Dobbert D; Schmiedel P; Seliger E; Dralle H
Surg Today; 2005; 35(10):846-54. PubMed ID: 16175466
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
